Date:
Saturday, January 11, 2025

Time:
7:30AM - Registration/
Continental Breakfast

8:30AM - Program Starts

3:00PM - Program Concludes

Venue:
Hotel Nikko 

222 Mason Street, San Francisco, CA
https://www.hotelnikkosf.com/

Regional Director
Hope S. Rugo, MD

Interested in Sponsorship Opportunites

www.bestofsabcs.com/sponsorship

 

Registration Fees: 

Physician (Non-ANCO Member): $75

ANCO Professional Member: $50

Nurse/Nurse Practitioner/ Physician Assistant: $35

Resident/Fellow: $25

Industry: $300

Best of SABCS West is organized in partnership with the Association of Northern California Oncologists (ANCO). 
 

This Activity is Supported by an Educational Grant from: 

AstraZeneca, Daiichi Sankyo, Exact Sciences, Pfizer, Stemline/Menarini, Puma Biotechnology

Program Overview

Breast cancer research continues to advance scientific and clinical knowledge of the disease and bring new techniques, treatments, and strategies to practicing clinicians. As such, clinicians need to stay current with best practices and clinical updates in prevention, screening, diagnosis, and treatment of breast cancer. Understanding results from recent clinical trials and key topics in breast cancer will help clinicians optimize management of patients with breast cancer and ultimately improve patient outcomes.

Learning Objectives

After completion of this program, attendees should be able to:

  • APPLY evidence-based strategies for preventing, detecting, and diagnosing breast cancer in at-risk patients.
  • CONDUCT biomarker and genetic testing in patients with breast cancer using evidence-based principles to identify actionable mutations and other tumor    characteristics that influence treatment approaches.
  • INCORPORATE new results from preclinical research and clinical trials in all aspects of breast cancer care presented during oral, poster and educational sessions at the annual San Antonio Breast Cancer Symposium into clinical practice.
  • INTEGRATE new data from clinical trials of novel therapeutics in breast cancer into local treatment patterns to align current practices with evidence based approaches, overcome resistance mechanisms, and enhance patient outcomes.
  • DESIGN treatment plans for patients with breast cancer using individualized treatment strategies based on breast cancer subtype, clinical characteristics, and patient preferences and goals to optimize therapy.

Final Agenda

Time Name Speakers
7:30 AM - 8:30 AM Registration, Continental Breakfast 
8:30 AM - 8:45 AMHope RugoWelcome and Introduction of Program and Faculty Pre-Knowledge AssessmentHope Rugo, University of California San Francisco, Helen Diller Family Comprehensive Cancer Center
8:45 AM - 9:15 AMMili AroraNew Directions in Breast Cancer Prevention and Approaches to Risk ReductionMili Arora, UC Davis Comprehensive Cancer Center
9:15 AM - 9:45 AMMark PegramInsights in Translational Research and Resistance MechanismsMark Pegram, Stanford University School of Medicine
9:45 AM - 10:15 AMRita MukhtarAdvances in Approaches to Local-regional disease (surgical and radiation)Rita Mukhtar, UCSF
10:15 AM - 10:45 AM Panel Question and Answer Session and Clinical Cases 
10:45 AM - 11:00 AM Refreshment Break 
11:00 AM - 11:30 AMRebecca ShatskyUpdates in Management of HR+ Metastatic DiseaseRebecca Shatsky, UC San Diego Moores Cancer Center
11:30 AM - 12:00 PMHelen ChewUpdates in the Management of HR+ Early Stage DiseaseHelen Chew, UC Davis Comprehensive Cancer Center
12:00 PM - 1:00 PM Lunch and Supported Symposium 
1:00 PM - 1:30 PMJo ChienUpdates in the Management of Triple Negative DiseaseJo Chien, UCSF Helen Diller Family Comprehensive Cancer Center
1:30 PM - 2:00 PMMelinda TelliUpdates in Management of HER2+ DiseaseMelinda Telli, Stanford University School of Medicine
2:00 PM - 2:30 PM Panel Questions and Answers session and Clinical Cases  
2:30 PM - 2:45 PMHope RugoWrap-up and Post TestHope Rugo, University of California San Francisco, Helen Diller Family Comprehensive Cancer Center
2:45 PM Adjournment 

Target Audience

This official Best of SABCS program is directed to practicing oncologists (medical, surgical, radiation), community physicians, medical residents and fellows training in oncology, as well as other pertinent healthcare professionals involved in oncology medicine.

Accreditation Statement

The UT Health Science Center San Antonio is accredited by the Accreditation Council for Continuing Medical Education to provide
continuing medical education for physicians.

The UT Health Science Center San Antonio has approved this program for AMA PRA Category 1 Credit™.

Location

Date

Moderator

 Status

San Francisco, CA

January 11

Hope Rugo, MD

Registration Closed

Atlanta, GA

January 25

Kevin Kalinsky, MD & Jane Meisel, MD

Registration Closed

New York, NY

February 8

Joseph Sparano, MD

Registration Closed

Orlando, FL

March 21

Eleftherios Mamounas, MD & Wassim Mchayleh, MD

Registration Open